COVID-19 and the ABO blood group connection. 2020

Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
University College of Medicine, The University of Lahore, Lahore, Pakistan. Electronic address: fatimaziazaidi@gmail.com.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093522 COVID-19 Serotherapy Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts. COVID-19 Convalescent Plasma Treatment,COVID-19 Convalescent Serum Treatment,COVID-19 Hyperimmune Globulin Therapy,COVID-19 Serum Therapy,COVID19 Hyperimmune Globulin Therapy,COVID19 Serotherapy,COVID19 Serum Therapy,Convalescent Plasma Treatment for Covid-19,Convalescent Serum Treatment for Covid-19,Coronavirus Disease 2019 Serotherapy,Coronavirus Disease-19 Serotherapy,Covid-19 Convalescent Sera Treatment,Hyperimmune Globulin Therapy for COVID-19,SARS-CoV-2 Convalescent Plasma Treatment,SARS-CoV-2 Convalescent Sera Treatment,SARS-CoV-2 Convalescent Serum Treatment,COVID-19 Serum Therapies,Convalescent Plasma Treatment for Covid 19,Convalescent Serum Treatment for Covid 19,Coronavirus Disease 19 Serotherapy,Coronavirus Disease-19 Serotherapies,Covid 19 Convalescent Sera Treatment,Disease-19 Serotherapies, Coronavirus,Serotherapies, COVID-19,Serotherapies, COVID19,Serotherapies, Coronavirus Disease-19,Serotherapy, COVID-19,Serotherapy, COVID19,Serotherapy, Coronavirus Disease-19,Serum Therapies, COVID-19,Serum Therapies, COVID19,Serum Therapy, COVID-19,Serum Therapy, COVID19,Therapies, COVID-19 Serum,Therapies, COVID19 Serum,Therapy, COVID-19 Serum,Therapy, COVID19 Serum
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group

Related Publications

Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
July 2020, British journal of haematology,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
June 2022, Journal of hematology,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
January 2023, Cambridge prisms. Precision medicine,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
September 2021, Vox sanguinis,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
January 2022, Hematology, transfusion and cell therapy,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
November 2022, American journal of clinical pathology,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
January 2021, Blood transfusion = Trasfusione del sangue,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
December 2021, Journal of infection in developing countries,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
September 2020, European journal of preventive cardiology,
Fatima Zia Zaidi, and Abdul Rehman Zia Zaidi, and Syed Maaz Abdullah, and Syed Ziauddin Ahmed Zaidi
March 2021, The Israel Medical Association journal : IMAJ,
Copied contents to your clipboard!